A cohort study showed that BRCA-related mutations are associated with a more aggressive phenotype, leading to a worse BC-related outcome when compared to other BC susceptibility genes such as ATM, CHEK2, STK11, NBN, PTEN, TP53, and PALB2 [13]. The gene discussed is STK11; the disease is breast cancer.